Partenaires

CNRS


Rechercher


Accueil > Publications > Recherche par années > Années 2010 > 2018

Anthiya S., Griveau A., Loussouarn C., Baril P., Garnett M., Issartel J. P. and Garcion E.

MicroRNA-Based Drugs for Brain Tumors.

Trends Cancer, (2018) 4 (3) 222-238.

par Frapart - publié le

Abstract :

MicroRNAs (miRNAs) are key regulatory elements encoded by the genome. A single miRNA can downregulate the expression of multiple genes involved in diverse functions. Because cancer is a disease with multiple gene aberrations, developing novel approaches to identify and modulate miRNA pathways may result in a breakthrough for cancer treatment. With a special focus on glioblastoma (GBM), this review provides an up-to-date summary of miRNA biogenesis, the role of miRNA in cancer resistance, and essential tools for modulating miRNA expression, as well as of clinically promising RNAi delivery systems and how they can be adapted for therapy.